Electrical Manipulation of the Failing Heart

Overview

Journal Heart Fail Rev

Date 2018 Aug 13

PMID 30099646

Authors

Valerio Zaca

Theodore Murphy

Mauro Biffi

Affiliations

Soon will be listed here.

Abstract

Chronic heart failure with reduced (≤ 40%) ejection fraction (HFrEF) poses a significant residual mortality risk despite modern optimal medical therapy. In the last decades, we have witnessed the introduction of breakthrough cardiac implantable electronic devices (CIED) aimed at addressing sudden cardiac death and HF progression in patients with HFrEF, leading to improved survival and functional capacity. Following their introduction, implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) have undergone substantial technological improvements and have been investigated in different settings of HFrEF, some of which yielded controversial results. In this review, we provide a comprehensive, yet pragmatic, approach to the individual key points in the electrical manipulation of the failing heart with ICD and CRT including patient selection, technological advances in the implant technique, follow-up, and long-term management. The aim of the review is to provide real-life-oriented advices to maximize the desired outcomes of CIED-based therapy of HFrEF. Accordingly, a framework to inform the decision-making process in candidates to ICD and/or CRT has been developed reflective of a critical appraisal of the most recently available evidence reappraising some domains beyond the classic views.

References

Biffi M . ICD programming. Indian Heart J. 2014; 66 Suppl 1:S88-100. PMC: 4237300. DOI: 10.1016/j.ihj.2013.11.007. View

Kober L, Thune J, Nielsen J, Haarbo J, Videbaek L, Korup E . Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med. 2016; 375(13):1221-30. DOI: 10.1056/NEJMoa1608029. View

Umar F, Taylor R, Stegemann B, Marshall H, Flannigan S, Lencioni M . Haemodynamic effects of cardiac resynchronization therapy using single-vein, three-pole, multipoint left ventricular pacing in patients with ischaemic cardiomyopathy and a left ventricular free wall scar: the MAESTRO study. Europace. 2016; 18(8):1227-34. DOI: 10.1093/europace/euv396. View

Mullens W, Grimm R, Verga T, Dresing T, Starling R, Wilkoff B . Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009; 53(9):765-73. DOI: 10.1016/j.jacc.2008.11.024. View

Gold M, Thebault C, Linde C, Abraham W, Gerritse B, Ghio S . Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation. 2012; 126(7):822-9. DOI: 10.1161/CIRCULATIONAHA.112.097709. View

Saxon L . Left ventricular versus biventricular for cardiac resynchronization therapy: comparable but not equal. Circulation. 2011; 124(25):2803-4. DOI: 10.1161/CIRCULATIONAHA.111.070763. View

Shamim W, Yousufuddin M, Cicoria M, Gibson D, Coats A, Henein M . Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart. 2002; 88(1):47-51. PMC: 1767184. DOI: 10.1136/heart.88.1.47. View

Hindricks G, Varma N, Kacet S, Lewalter T, Sogaard P, Guedon-Moreau L . Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J. 2018; 38(22):1749-1755. PMC: 5461472. DOI: 10.1093/eurheartj/ehx015. View

Gage R, Curtin A, Burns K, Ghosh S, Gillberg J, Bank A . Changes in electrical dyssynchrony by body surface mapping predict left ventricular remodeling in patients with cardiac resynchronization therapy. Heart Rhythm. 2016; 14(3):392-399. DOI: 10.1016/j.hrthm.2016.11.019. View

10.

Van der Bijl P, Delgado V, Bax J . Sudden cardiac death: The role of imaging. Int J Cardiol. 2017; 237:15-18. DOI: 10.1016/j.ijcard.2017.03.010. View

11.

Ploux S, Lumens J, Whinnett Z, Montaudon M, Strom M, Ramanathan C . Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology. J Am Coll Cardiol. 2013; 61(24):2435-2443. DOI: 10.1016/j.jacc.2013.01.093. View

12.

Boule S, Ninni S, Finat L, Botcherby E, Kouakam C, Klug D . Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring. Europace. 2015; 18(12):1809-1817. DOI: 10.1093/europace/euv392. View

13.

Sapp J, Wells G, Parkash R, Stevenson W, Blier L, Sarrazin J . Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med. 2016; 375(2):111-21. DOI: 10.1056/NEJMoa1513614. View

14.

Lopes R, Alings M, Connolly S, Beresh H, Granger C, Benezet Mazuecos J . Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. Am Heart J. 2017; 189:137-145. DOI: 10.1016/j.ahj.2017.04.008. View

15.

de Guillebon M, Thambo J, Ploux S, Deplagne A, Sacher F, Jais P . Reliability and reproducibility of QRS duration in the selection of candidates for cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2010; 21(8):890-2. DOI: 10.1111/j.1540-8167.2010.01743.x. View

16.

Turakhia M, Schiller N, Whooley M . Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol. 2008; 102(9):1131-5. PMC: 2583450. DOI: 10.1016/j.amjcard.2008.06.036. View

17.

Metra M, Zaca V, Parati G, Agostoni P, Bonadies M, Ciccone M . Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown). 2010; 12(2):76-84. DOI: 10.2459/JCM.0b013e32834058d1. View

18.

Lakkireddy D, Di Biase L, Ryschon K, Biria M, Swarup V, Reddy Y . Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. J Am Coll Cardiol. 2012; 60(16):1531-9. DOI: 10.1016/j.jacc.2012.06.035. View

19.

Leyva F, Zegard A, Qiu T, Acquaye E, Ferrante G, Walton J . Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization. J Am Heart Assoc. 2017; 6(10). PMC: 5721885. DOI: 10.1161/JAHA.117.007026. View

20.

Tomlinson D, Bashir Y, Betts T, Rajappan K . Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace. 2009; 11(5):638-42. DOI: 10.1093/europace/eup001. View